Detalhe da pesquisa
1.
Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.
N Engl J Med
; 387(9): 810-823, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36053506
2.
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.
N Engl J Med
; 382(10): 893-902, 2020 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32130813
3.
Effect of Clofazimine Concentration on QT Prolongation in Patients Treated for Tuberculosis.
Antimicrob Agents Chemother
; 65(7): e0268720, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33875426
4.
An Exposure-Response Perspective on the Clinical Dose of Pretomanid.
Antimicrob Agents Chemother
; 65(1)2020 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33077660
5.
Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis.
Antimicrob Agents Chemother
; 64(4)2020 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31988102
6.
Clofazimine pharmacokinetics in patients with TB: dosing implications.
J Antimicrob Chemother
; 75(11): 3269-3277, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32747933
7.
Population Pharmacokinetics of the Antituberculosis Agent Pretomanid.
Antimicrob Agents Chemother
; 63(10)2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31405856
8.
Long-Term Effects on QT Prolongation of Pretomanid Alone and in Combinations in Patients with Tuberculosis.
Antimicrob Agents Chemother
; 63(10)2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31358590
9.
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. Reply.
N Engl J Med
; 382(24): 2377, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32521143
10.
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.
Lancet
; 385(9979): 1738-1747, 2015 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25795076
11.
Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System.
J Clin Microbiol
; 54(5): 1276-81, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26912751
12.
Bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline.
Am J Respir Crit Care Med
; 191(8): 943-53, 2015 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25622149
13.
Reply to Kim et al., "Optimal Dose or Optimal Exposure? Consideration for Linezolid in Tuberculosis Treatment".
Antimicrob Agents Chemother
; 64(7)2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32366714
14.
Effect of a high-calorie, high-fat meal on the bioavailability and pharmacokinetics of PA-824 in healthy adult subjects.
Antimicrob Agents Chemother
; 57(11): 5516-20, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23979737
15.
Evaluation of pharmacokinetic interaction between PA-824 and midazolam in healthy adult subjects.
Antimicrob Agents Chemother
; 57(8): 3699-703, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23689718
16.
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.
Lancet
; 380(9846): 986-93, 2012 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22828481
17.
Phase 1 Study of the Effects of the Tuberculosis Treatment Pretomanid, Alone and in Combination With Moxifloxacin, on the QTc Interval in Healthy Volunteers.
Clin Pharmacol Drug Dev
; 10(6): 634-646, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33378139
18.
Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines.
BMJ Open
; 11(12): e051521, 2021 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34862287
19.
Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial.
Lancet Respir Med
; 7(12): 1048-1058, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31732485
20.
Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis.
J Clin Pharmacol
; 47(3): 383-96, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17322150